$OPK
OPKO HEALTH, INC.

2024 Q3 Form 10-Q Financial Statement

#000143774924025185 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $173.6M $182.2M
YoY Change -2.78% -31.35%
Cost Of Revenue $133.5M $130.5M
YoY Change 1.99% -6.02%
Gross Profit $40.13M $51.65M
YoY Change -15.87% -59.17%
Gross Profit Margin 23.11% 28.35%
Selling, General & Admin $98.20M $68.82M
YoY Change 35.94% -13.76%
% of Gross Profit 244.72% 133.24%
Research & Development $28.77M $24.08M
YoY Change 48.03% 32.32%
% of Gross Profit 71.69% 46.62%
Depreciation & Amortization $24.16M $24.16M
YoY Change -7.71% 12.35%
% of Gross Profit 60.21% 46.76%
Operating Expenses $159.4M $243.9M
YoY Change -34.4% 104.06%
Operating Profit $14.22M -$61.67M
YoY Change -122.07% -981.0%
Interest Expense -$14.43M -$7.788M
YoY Change -526.48% -337.66%
% of Operating Profit -101.52%
Other Income/Expense, Net $34.20M $51.09M
YoY Change -344.82% -317.39%
Pretax Income $48.42M -$10.58M
YoY Change -161.78% -35.85%
Income Tax $23.53M -$280.0K
% Of Pretax Income 48.59%
Net Earnings $24.89M -$10.31M
YoY Change -129.47% -47.42%
Net Earnings / Revenue 14.33% -5.66%
Basic Earnings Per Share $0.04 -$0.01
Diluted Earnings Per Share $0.03 -$0.01
COMMON SHARES
Basic Shares Outstanding 697.4M 697.0M
Diluted Shares Outstanding 998.4M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $406.4M $40.58M
YoY Change 193.22% -62.46%
Cash & Equivalents $400.1M $40.58M
Short-Term Investments
Other Short-Term Assets $9.295M $6.734M
YoY Change 32.73% -97.93%
Inventory $59.41M $60.15M
Prepaid Expenses
Receivables $106.6M $105.3M
Other Receivables $32.08M $10.70M
Total Short-Term Assets $629.6M $358.0M
YoY Change 76.25% -17.48%
LONG-TERM ASSETS
Property, Plant & Equipment $135.1M $66.77M
YoY Change 72.81% -15.35%
Goodwill $535.9M $530.1M
YoY Change -9.86% -11.26%
Intangibles $641.4M $659.1M
YoY Change -15.43% -15.74%
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $18.51M $7.796M
YoY Change 98.34% -99.16%
Total Long-Term Assets $1.626B $1.622B
YoY Change -4.29% -5.98%
TOTAL ASSETS
Total Short-Term Assets $629.6M $358.0M
Total Long-Term Assets $1.626B $1.622B
Total Assets $2.256B $1.980B
YoY Change 9.7% -8.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $62.72M $82.24M
YoY Change -6.11% -6.44%
Accrued Expenses $122.8M $94.52M
YoY Change 32.95% -4.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.509M $1.597M
YoY Change -14.84%
Total Short-Term Liabilities $211.7M $219.6M
YoY Change 5.54% -3.02%
LONG-TERM LIABILITIES
Long-Term Debt $3.529M $3.676M
YoY Change -55.48% -98.27%
Other Long-Term Liabilities $36.50M $20.32M
YoY Change 42.5% -60.86%
Total Long-Term Liabilities $641.0M $365.0M
YoY Change 55.76% 38.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $211.7M $219.6M
Total Long-Term Liabilities $641.0M $365.0M
Total Liabilities $852.7M $584.6M
YoY Change 39.3% -6.26%
SHAREHOLDERS EQUITY
Retained Earnings -$2.079B -$2.104B
YoY Change 6.87% 13.06%
Common Stock $7.124M $7.273M
YoY Change -8.87% -6.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.403B $1.395B
YoY Change
Total Liabilities & Shareholders Equity $2.256B $1.980B
YoY Change 9.7% -8.29%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $24.89M -$10.31M
YoY Change -129.47% -47.42%
Depreciation, Depletion And Amortization $24.16M $24.16M
YoY Change -7.71% 12.35%
Cash From Operating Activities -$77.08M -$26.43M
YoY Change -332.87% 7142.47%
INVESTING ACTIVITIES
Capital Expenditures $7.937M $7.217M
YoY Change 88.98% 20.02%
Acquisitions
YoY Change
Other Investing Activities $255.7M $55.00K
YoY Change 36431.57% -89.46%
Cash From Investing Activities $247.8M -$7.162M
YoY Change -6982.89% 30.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 206.1M -2.115M
YoY Change 9716.19% -161.09%
NET CHANGE
Cash From Operating Activities -77.08M -26.43M
Cash From Investing Activities 247.8M -7.162M
Cash From Financing Activities 206.1M -2.115M
Net Change In Cash 376.8M -35.71M
YoY Change 1092.55% 1391.73%
FREE CASH FLOW
Cash From Operating Activities -$77.08M -$26.43M
Capital Expenditures $7.937M $7.217M
Free Cash Flow -$85.02M -$33.65M
YoY Change -394.17% 427.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
727176232
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
781936885
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
29800177
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
8655082
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
900000000 usd
us-gaap Open Tax Year
OpenTaxYear
2015 2016 2017 2018 2019 2020 2021
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2024Q3 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33528
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2402409
dei Entity Address Address Line1
EntityAddressAddressLine1
4400 Biscayne Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
dei City Area Code
CityAreaCode
305
dei Local Phone Number
LocalPhoneNumber
575-4100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
OPK
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
697376055
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40576000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95881000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105313000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
123379000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
60153000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
65697000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32288000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24519000 usd
CY2024Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
119651000 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
357981000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
309476000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66766000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75429000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
659111000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
740283000 usd
CY2024Q2 opk Capitalized Research And Development In Process
CapitalizedResearchAndDevelopmentInProcess
195000000 usd
CY2023Q4 opk Capitalized Research And Development In Process
CapitalizedResearchAndDevelopmentInProcess
195000000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
530106000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
598260000 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
101489000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
16082000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61622000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68088000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7796000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9080000 usd
CY2024Q2 us-gaap Assets
Assets
1979871000 usd
CY2023Q4 us-gaap Assets
Assets
2011698000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
82242000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
69677000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
94516000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
90086000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11624000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12996000 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
170000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2024Q2 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
22129000 usd
CY2023Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
27293000 usd
CY2024Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
8872000 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
219553000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
200052000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
49624000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54140000 usd
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
175942000 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
214325000 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
119120000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
126773000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20315000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27189000 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
365001000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
422427000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
584554000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
622479000 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
7273000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7820000 usd
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1791000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1791000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3540414000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3433006000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-46652000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-38030000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2103927000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2011786000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1395317000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1389219000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1979871000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2011698000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
182186000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
265418000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
355872000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
502995000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68821000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79794000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
138988000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
155436000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24082000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18159000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46020000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50764000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-34000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
102000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20420000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21535000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41856000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43009000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
243856000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
258393000 usd
us-gaap Operating Expenses
OperatingExpenses
489015000 usd
us-gaap Operating Expenses
OperatingExpenses
526564000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-61670000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7025000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-133143000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-23569000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
391000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1077000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1204000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2107000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8180000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3277000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15865000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6668000 usd
CY2024Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1000 usd
CY2023Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
142000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-26160000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-917000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58874000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21417000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
80197000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4400000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
51086000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23475000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
39376000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9878000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10584000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16450000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-93767000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-33447000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-280000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3148000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1629000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4381000 usd
CY2024Q2 opk Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total
IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterestTotal
-10304000 usd
CY2023Q2 opk Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total
IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterestTotal
-19598000 usd
opk Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total
IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterestTotal
-92138000 usd
opk Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total
IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterestTotal
-37828000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-42000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-79000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-10305000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-19640000 usd
us-gaap Net Income Loss
NetIncomeLoss
-92141000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37907000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
697211592
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
751727383
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
702036148
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
751617431
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-10305000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-19640000 usd
us-gaap Net Income Loss
NetIncomeLoss
-92141000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37907000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1457000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
670000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8622000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6381000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11762000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18970000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-100763000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31526000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1252808000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2609000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-208000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-10305000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1457000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1395317000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1389219000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5199000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-208000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-92141000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8622000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1395317000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1551810000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2810000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-301000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-19640000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
669000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1535348000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1561648000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5527000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-301000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37907000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6381000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1535348000 usd
us-gaap Net Income Loss
NetIncomeLoss
-92141000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37907000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
49974000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52993000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
8138000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
1364000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
946000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
598000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-79000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5199000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5527000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
69000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-2075000 usd
opk Changes In Fair Value Gain Loss In Equity Securities Fvni And Derivative Instruments
ChangesInFairValueGainLossInEquitySecuritiesFvniAndDerivativeInstruments
59248000 usd
opk Changes In Fair Value Gain Loss In Equity Securities Fvni And Derivative Instruments
ChangesInFairValueGainLossInEquitySecuritiesFvniAndDerivativeInstruments
-6146000 usd
opk Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
-757000 usd
opk Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
-0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
102000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4477000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1753000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15353000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
81822000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1732000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2749000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7817000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1279000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
116000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1915000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13688000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20210000 usd
opk Increase Decrease In Foreign Currency Measurement
IncreaseDecreaseInForeignCurrencyMeasurement
2638000 usd
opk Increase Decrease In Foreign Currency Measurement
IncreaseDecreaseInForeignCurrencyMeasurement
-1318000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3439000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
5073000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62001000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23012000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5000000 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
103000 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
842000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
11660000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9050000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11557000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13208000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
230000000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8562000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
opk Proceeds From Repurchase Of Stock Options And Warrants Exercised
ProceedsFromRepurchaseOfStockOptionsAndWarrantsExercised
-208000 usd
opk Proceeds From Repurchase Of Stock Options And Warrants Exercised
ProceedsFromRepurchaseOfStockOptionsAndWarrantsExercised
-301000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
317811000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
341850000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
324256000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
348206000 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
146287000 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
3000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18498000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9657000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-245000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
794000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-55305000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-45083000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95881000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153191000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40576000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108108000 usd
us-gaap Interest Paid Net
InterestPaidNet
3517000 usd
us-gaap Interest Paid Net
InterestPaidNet
4204000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1576000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
685000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
181000 usd
opk Common Stock Options And Warrants Net Exercised
CommonStockOptionsAndWarrantsNetExercised
208000 usd
opk Common Stock Options And Warrants Net Exercised
CommonStockOptionsAndWarrantsNetExercised
301000 usd
opk Shares Included In Business Divesture Cash Flow Impact
SharesIncludedInBusinessDivestureCashFlowImpact
0 usd
opk Shares Included In Business Divesture Cash Flow Impact
SharesIncludedInBusinessDivestureCashFlowImpact
6689000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
43300000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
34600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"><i>Use of estimates</i>. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"></p>
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
600000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1000000 usd
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
800000 usd
us-gaap Inventory Write Down
InventoryWriteDown
2200000 usd
CY2024Q2 opk Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill And Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets
1400000000 usd
CY2023Q4 opk Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill And Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets
1500000000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
530100000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
598300000 usd
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
900000000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41900000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43000000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
3700000 usd
us-gaap Depreciation
Depreciation
8100000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
5000000 usd
us-gaap Depreciation
Depreciation
10000000 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
9900000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"><i>Concentration of credit risk and allowance for credit losses</i>. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of accounts receivable. Substantially all of our accounts receivable are with either companies in the healthcare industry or patients. However, credit risk is limited due to the number of our clients as well as their dispersion across many different geographic regions.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">While we have receivables due from federal and state governmental agencies, such receivables are <em style="font: inherit;">not</em> a credit risk because federal and state governments fund the related healthcare programs. Payment is primarily dependent upon submitting appropriate documentation. On <em style="font: inherit;"> June 30, 2024</em> and <em style="font: inherit;"> December 31, 2023</em>, receivable balances (net of explicit and implicit price concessions) from Medicare and Medicaid were 7.8% and 6.7%, respectively, of our consolidated Accounts receivable, net. The portion of our accounts receivable due from individual patients comprises the largest portion of credit risk. At <em style="font: inherit;"> June 30, 2024</em> and <em style="font: inherit;"> December 31, 2023</em>, receivables due from patients represented approximately 2.1% and 2.0%, respectively, of our consolidated Accounts receivable, net.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">We assess the collectability of accounts receivable balances by considering factors such as historical collection experience, customer credit worthiness, the age of accounts receivable balances, regulatory changes and current economic conditions and trends that <em style="font: inherit;"> may </em>affect a customer’s ability to pay. Actual results could differ from those estimates. The allowance for credit losses was $2.0 million on each of  <em style="font: inherit;"> June 30, 2024</em> and <em style="font: inherit;"> December 31, 2023</em>. The credit loss expense for the <em style="font: inherit;">three</em> and <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2024</em>, was $14.1 thousand and $142.6 thousand, respectively. The credit loss expense for the <em style="font: inherit;">three</em> and <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2023</em>, was $2.8 thousand and $88.0 thousand, respectively.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">As of <em style="font: inherit;"> June 30, 2024</em>, accounts receivable included $1.2 million of revenue earned under the BARDA Contract (as defined in Note <em style="font: inherit;">14</em>). As of <em style="font: inherit;"> December 31, 2023, </em>accounts receivable included $0.6 million under this contract. Refer to Note <em style="font: inherit;">13,</em> Government Contract Revenue for further information on government contracts and to Note <em style="font: inherit;">14,</em> Strategic Alliances for further information on the BARDA Contract.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"></p>
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000000 usd
CY2024Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14100 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
142600 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2800 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
88000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2600000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5200000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2800000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5500000 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1300000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4000000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
900000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2000000 usd
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
294774975
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
82817175
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
293731532
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
82438648
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2024Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
549687
CY2024Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
384378
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
549687
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
384378
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
549680
CY2023Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
386971
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
549680
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
386971
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
107310000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
125379000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1997000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105313000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
123379000 usd
CY2024Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
18011000 usd
CY2023Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
25864000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34478000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35582000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2203000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1731000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
9269000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8981000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3808000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6461000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
60153000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
65697000 usd
CY2024Q2 us-gaap Prepaid Taxes
PrepaidTaxes
4897000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
4211000 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
9453000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6177000 usd
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
5399000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3848000 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
5805000 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2610000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
6734000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7673000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32288000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24519000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
490678000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
488694000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
659111000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
740283000 usd
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
27158000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
28952000 usd
CY2024Q2 opk Accrued Clinical Trials
AccruedClinicalTrials
5779000 usd
CY2023Q4 opk Accrued Clinical Trials
AccruedClinicalTrials
7624000 usd
CY2024Q2 opk Accrued Commitments And Contingencies Current
AccruedCommitmentsAndContingenciesCurrent
8842000 usd
CY2023Q4 opk Accrued Commitments And Contingencies Current
AccruedCommitmentsAndContingenciesCurrent
8088000 usd
CY2024Q2 opk Accrued Gross To Net Provision
AccruedGrossToNetProvision
7808000 usd
CY2023Q4 opk Accrued Gross To Net Provision
AccruedGrossToNetProvision
9420000 usd
CY2024Q2 opk Accrued Inventory Not Yet Billed
AccruedInventoryNotYetBilled
3608000 usd
CY2023Q4 opk Accrued Inventory Not Yet Billed
AccruedInventoryNotYetBilled
1653000 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1787000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2827000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2672000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3470000 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
5780000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1384000 usd
CY2024Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
880000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1544000 usd
CY2024Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1960000 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1822000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28242000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23302000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
94516000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
90086000 usd
CY2024Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
3676000 usd
CY2023Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
7709000 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4497000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
7274000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7000 usd
CY2024Q2 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
12135000 usd
CY2023Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
12199000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20315000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27189000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
636283000 usd
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
38023000 usd
opk Goodwill Acquired Disposed Of During Period
GoodwillAcquiredDisposedOfDuringPeriod
-65294000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2860000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
530106000 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
-0 usd
CY2024Q2 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
2649000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
-0 usd
CY2023Q4 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
2942000 usd
CY2024Q2 opk Equity Method Investment Variable Interest Entity
EquityMethodInvestmentVariableInterestEntity
793000 usd
CY2024Q2 opk Equity Method Investment Variable Interest Entity Underlying Equity In Net Assets
EquityMethodInvestmentVariableInterestEntityUnderlyingEquityInNetAssets
0 usd
CY2023Q4 opk Equity Method Investment Variable Interest Entity
EquityMethodInvestmentVariableInterestEntity
796000 usd
CY2023Q4 opk Equity Method Investment Variable Interest Entity Underlying Equity In Net Assets
EquityMethodInvestmentVariableInterestEntityUnderlyingEquityInNetAssets
420000 usd
CY2024Q2 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
93022000 usd
CY2023Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
9786000 usd
CY2024Q2 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
149000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
116000 usd
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
7521000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
5382000 usd
CY2024Q2 opk Equity Investments Carrying Value Of Equity Intruments
EquityInvestmentsCarryingValueOfEquityIntruments
4000 usd
CY2023Q4 opk Equity Investments Carrying Value Of Equity Intruments
EquityInvestmentsCarryingValueOfEquityIntruments
2000 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
101489000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
16082000 usd
CY2024Q2 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
700000 usd
CY2023Q4 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
700000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
33000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-318000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
33000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-318000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1597000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1993000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3676000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7727000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
201917000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
249345000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
201917000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
249345000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000000 usd
CY2024Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
0.9067
CY2024Q2 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
pure
CY2024Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
79872000 usd
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
20532000 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
25300000 usd
CY2019Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
29500
CY2019Q3 opk Operating Leases Monthly Payments Year One
OperatingLeasesMonthlyPaymentsYearOne
89000 usd
CY2019Q3 opk Operating Leases Monthly Payments Year Five
OperatingLeasesMonthlyPaymentsYearFive
101000 usd
CY2024Q2 us-gaap Purchase Obligation
PurchaseObligation
45800000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
900000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
13900000 usd
CY2024Q2 opk Accrued Expense Payor Overpayment Reimbursement Liability
AccruedExpensePayorOverpaymentReimbursementLiability
5200000 usd
CY2023Q4 opk Accrued Expense Payor Overpayment Reimbursement Liability
AccruedExpensePayorOverpaymentReimbursementLiability
3100000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-61670000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7025000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-133143000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-23569000 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24155000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26391000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
49974000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52993000 usd
CY2024Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-42000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-3000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-79000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
182186000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
265418000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
355872000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
502995000 usd
CY2024Q2 us-gaap Assets
Assets
1979871000 usd
CY2023Q4 us-gaap Assets
Assets
2011698000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
530106000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
598260000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61622000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68088000 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
6284000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
10101000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11624000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12996000 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1787000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2827000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
49624000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54140000 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4497000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
7274000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y9M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M6D
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M24D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P6Y2M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.054 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.054 pure
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.027 pure
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.038 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6217000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
1085000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11220000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1550000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10367000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1086000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10194000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
659000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9985000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
195000 usd
CY2024Q2 opk Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
25769000 usd
CY2024Q2 opk Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
1881000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
73752000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
6456000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12504000 usd
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
172000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
61248000 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
6284000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
9200000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1300000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1000000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
8200000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1400000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
600000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
9113000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
7955000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
238000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
206000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1268000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1268000 usd
opk Payments For Leases
PaymentsForLeases
10619000 usd
opk Payments For Leases
PaymentsForLeases
9429000 usd

Files In Submission

Name View Source Status
opk-20240630_cal.xml Edgar Link unprocessable
0001437749-24-025185-index-headers.html Edgar Link pending
0001437749-24-025185-index.html Edgar Link pending
0001437749-24-025185.txt Edgar Link pending
0001437749-24-025185-xbrl.zip Edgar Link pending
ex_677908.htm Edgar Link pending
ex_677909.htm Edgar Link pending
ex_677910.htm Edgar Link pending
ex_677911.htm Edgar Link pending
ex_708391.htm Edgar Link pending
ex_708392.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
opk-20240630.xsd Edgar Link pending
opk20240630_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
opk-20240630_def.xml Edgar Link unprocessable
opk-20240630_lab.xml Edgar Link unprocessable
opk-20240630_pre.xml Edgar Link unprocessable
opk20240630_10q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending